A metalloproteinase karilysin present in the majority of Tannerella forsythia isolates inhibits all pathways of the complement system

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

A metalloproteinase karilysin present in the majority of Tannerella forsythia isolates inhibits all pathways of the complement system. / Jusko, Monika; Potempa, Jan; Karim, Abdulkarim Y; Ksiazek, Miroslaw; Riesbeck, Kristian; Garred, Peter; Eick, Sigrun; Blom, Anna M.

In: Journal of Immunology, Vol. 188, No. 5, 2012, p. 2338-49.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Jusko, M, Potempa, J, Karim, AY, Ksiazek, M, Riesbeck, K, Garred, P, Eick, S & Blom, AM 2012, 'A metalloproteinase karilysin present in the majority of Tannerella forsythia isolates inhibits all pathways of the complement system', Journal of Immunology, vol. 188, no. 5, pp. 2338-49. https://doi.org/10.4049/jimmunol.1101240

APA

Jusko, M., Potempa, J., Karim, A. Y., Ksiazek, M., Riesbeck, K., Garred, P., Eick, S., & Blom, A. M. (2012). A metalloproteinase karilysin present in the majority of Tannerella forsythia isolates inhibits all pathways of the complement system. Journal of Immunology, 188(5), 2338-49. https://doi.org/10.4049/jimmunol.1101240

Vancouver

Jusko M, Potempa J, Karim AY, Ksiazek M, Riesbeck K, Garred P et al. A metalloproteinase karilysin present in the majority of Tannerella forsythia isolates inhibits all pathways of the complement system. Journal of Immunology. 2012;188(5):2338-49. https://doi.org/10.4049/jimmunol.1101240

Author

Jusko, Monika ; Potempa, Jan ; Karim, Abdulkarim Y ; Ksiazek, Miroslaw ; Riesbeck, Kristian ; Garred, Peter ; Eick, Sigrun ; Blom, Anna M. / A metalloproteinase karilysin present in the majority of Tannerella forsythia isolates inhibits all pathways of the complement system. In: Journal of Immunology. 2012 ; Vol. 188, No. 5. pp. 2338-49.

Bibtex

@article{02d3a03d2eb24f6ea1cbaaa7d9918097,
title = "A metalloproteinase karilysin present in the majority of Tannerella forsythia isolates inhibits all pathways of the complement system",
abstract = "Tannerella forsythia is a poorly studied pathogen despite being one of the main causes of periodontitis, which is an inflammatory disease of the supporting structures of the teeth. We found that despite being recognized by all complement pathways, T. forsythia is resistant to killing by human complement, which is present at up to 70% of serum concentration in gingival crevicular fluid. Incubation of human serum with karilysin, a metalloproteinase of T. forsythia, resulted in a decrease in bactericidal activity of the serum. T. forsythia strains expressing karilysin at higher levels were more resistant than low-expressing strains. Furthermore, the low-expressing strain was significantly more opsonized with activated complement factor 3 and membrane attack complex from serum compared with the other strains. The high-expressing strain was more resistant to killing in human blood. The protective effect of karilysin against serum bactericidal activity was attributable to its ability to inhibit complement at several stages. The classical and lectin complement pathways were inhibited because of the efficient degradation of mannose-binding lectin, ficolin-2, ficolin-3, and C4 by karilysin, whereas inhibition of the terminal pathway was caused by degradation of C5. Interestingly, karilysin was able to release biologically active C5a peptide in human plasma and induce migration of neutrophils. Importantly, we detected the karilysin gene in >90% of gingival crevicular fluid samples containing T. forsythia obtained from patients with periodontitis. Taken together, the newly characterized karilysin appears to be an important virulence factor of T. forsythia and might have several important implications for immune evasion.",
author = "Monika Jusko and Jan Potempa and Karim, {Abdulkarim Y} and Miroslaw Ksiazek and Kristian Riesbeck and Peter Garred and Sigrun Eick and Blom, {Anna M}",
year = "2012",
doi = "10.4049/jimmunol.1101240",
language = "English",
volume = "188",
pages = "2338--49",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "5",

}

RIS

TY - JOUR

T1 - A metalloproteinase karilysin present in the majority of Tannerella forsythia isolates inhibits all pathways of the complement system

AU - Jusko, Monika

AU - Potempa, Jan

AU - Karim, Abdulkarim Y

AU - Ksiazek, Miroslaw

AU - Riesbeck, Kristian

AU - Garred, Peter

AU - Eick, Sigrun

AU - Blom, Anna M

PY - 2012

Y1 - 2012

N2 - Tannerella forsythia is a poorly studied pathogen despite being one of the main causes of periodontitis, which is an inflammatory disease of the supporting structures of the teeth. We found that despite being recognized by all complement pathways, T. forsythia is resistant to killing by human complement, which is present at up to 70% of serum concentration in gingival crevicular fluid. Incubation of human serum with karilysin, a metalloproteinase of T. forsythia, resulted in a decrease in bactericidal activity of the serum. T. forsythia strains expressing karilysin at higher levels were more resistant than low-expressing strains. Furthermore, the low-expressing strain was significantly more opsonized with activated complement factor 3 and membrane attack complex from serum compared with the other strains. The high-expressing strain was more resistant to killing in human blood. The protective effect of karilysin against serum bactericidal activity was attributable to its ability to inhibit complement at several stages. The classical and lectin complement pathways were inhibited because of the efficient degradation of mannose-binding lectin, ficolin-2, ficolin-3, and C4 by karilysin, whereas inhibition of the terminal pathway was caused by degradation of C5. Interestingly, karilysin was able to release biologically active C5a peptide in human plasma and induce migration of neutrophils. Importantly, we detected the karilysin gene in >90% of gingival crevicular fluid samples containing T. forsythia obtained from patients with periodontitis. Taken together, the newly characterized karilysin appears to be an important virulence factor of T. forsythia and might have several important implications for immune evasion.

AB - Tannerella forsythia is a poorly studied pathogen despite being one of the main causes of periodontitis, which is an inflammatory disease of the supporting structures of the teeth. We found that despite being recognized by all complement pathways, T. forsythia is resistant to killing by human complement, which is present at up to 70% of serum concentration in gingival crevicular fluid. Incubation of human serum with karilysin, a metalloproteinase of T. forsythia, resulted in a decrease in bactericidal activity of the serum. T. forsythia strains expressing karilysin at higher levels were more resistant than low-expressing strains. Furthermore, the low-expressing strain was significantly more opsonized with activated complement factor 3 and membrane attack complex from serum compared with the other strains. The high-expressing strain was more resistant to killing in human blood. The protective effect of karilysin against serum bactericidal activity was attributable to its ability to inhibit complement at several stages. The classical and lectin complement pathways were inhibited because of the efficient degradation of mannose-binding lectin, ficolin-2, ficolin-3, and C4 by karilysin, whereas inhibition of the terminal pathway was caused by degradation of C5. Interestingly, karilysin was able to release biologically active C5a peptide in human plasma and induce migration of neutrophils. Importantly, we detected the karilysin gene in >90% of gingival crevicular fluid samples containing T. forsythia obtained from patients with periodontitis. Taken together, the newly characterized karilysin appears to be an important virulence factor of T. forsythia and might have several important implications for immune evasion.

U2 - 10.4049/jimmunol.1101240

DO - 10.4049/jimmunol.1101240

M3 - Journal article

C2 - 22287711

VL - 188

SP - 2338

EP - 2349

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 5

ER -

ID: 48448923